Galectins as Molecular Targets for Therapeutic Intervention
Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting β-galactoside epitopes. Because of their significant...
Saved in:
Published in | International journal of molecular sciences Vol. 19; no. 3; p. 905 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
19.03.2018
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting β-galactoside epitopes. Because of their significant involvement in various biological functions and pathologies, galectins have become a focus of therapeutic discovery for clinical intervention against cancer, among other pathological disorders. In this review, we focus on understanding galectin structure-function relationships, their mechanisms of action on the molecular level, and targeting them for therapeutic intervention against cancer. |
---|---|
AbstractList | Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and that function by interacting with various cell surface glycoconjugates, usually targeting β-galactoside epitopes. Because of their significant involvement in various biological functions and pathologies, galectins have become a focus of therapeutic discovery for clinical intervention against cancer, among other pathological disorders. In this review, we focus on understanding galectin structure-function relationships, their mechanisms of action on the molecular level, and targeting them for therapeutic intervention against cancer. |
Author | Dings, Ruud P M Miller, Michelle C Mayo, Kevin H Griffin, Robert J |
AuthorAffiliation | 1 Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; rpmdings@uams.edu (R.P.M.D.); rjgriffin@usma.edu (R.J.G.) 2 Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, MN 55455, USA; mill0935@umn.edu |
AuthorAffiliation_xml | – name: 2 Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, MN 55455, USA; mill0935@umn.edu – name: 1 Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA; rpmdings@uams.edu (R.P.M.D.); rjgriffin@usma.edu (R.J.G.) |
Author_xml | – sequence: 1 givenname: Ruud P M orcidid: 0000-0001-7686-1331 surname: Dings fullname: Dings, Ruud P M email: rpmdings@uams.edu organization: Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. rpmdings@uams.edu – sequence: 2 givenname: Michelle C orcidid: 0000-0002-7860-5785 surname: Miller fullname: Miller, Michelle C email: mill0935@umn.edu organization: Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, MN 55455, USA. mill0935@umn.edu – sequence: 3 givenname: Robert J surname: Griffin fullname: Griffin, Robert J email: rjgriffin@usma.edu organization: Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. rjgriffin@usma.edu – sequence: 4 givenname: Kevin H surname: Mayo fullname: Mayo, Kevin H email: mayox001@umn.edu organization: Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, MN 55455, USA. mayox001@umn.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29562695$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1v1DAQxS3Uin7AjTOKxIUDS8dfcSykSqiCslKrXsrZGseTbVbZeLGTSvz3eNlSbTl5bP_0Zt68M3Y0xpEYe8fhs5QWLvr1JnMLEizoV-yUKyEWALU5OqhP2FnOawAhhbav2Ymwuha11afsyzUO1E79mCvM1W0sl3nAVN1jWtGUqy6W-oESbmme-rZajhOlRxqnPo5v2HGHQ6a3T-c5-_n92_3Vj8XN3fXy6uvNotVKTQuUSngRoAk8dEDGNkBeCi684pY6DjVgaMA2pm5EF8h4b3YgkLRI2stzttzrhohrt039BtNvF7F3fx9iWjlMZbiBnBdeFms-kEalqEP0oQm-taWNV6ouWpd7re3sNxTa4iTh8EL05c_YP7hVfHS6McbUO4GPTwIp_popT27T55aGAUeKc3YCuAFdl9UX9MN_6DrOaSyrcoJDo3RBd9SnPdWmmHOi7nkYDm6XsDtMuODvDw08w_8ilX8A62akJA |
CitedBy_id | crossref_primary_10_1039_C9CP04881B crossref_primary_10_3390_biology11010088 crossref_primary_10_3390_pharmaceutics15030729 crossref_primary_10_3389_falgy_2022_840454 crossref_primary_10_1042_BCJ20200167 crossref_primary_10_1371_journal_pone_0238441 crossref_primary_10_3390_ijms22116000 crossref_primary_10_1016_j_jemermed_2022_04_001 crossref_primary_10_1039_C9MD00292H crossref_primary_10_3389_fcvm_2023_1052959 crossref_primary_10_3390_ijms241512305 crossref_primary_10_1021_jasms_4c00052 crossref_primary_10_1186_s12964_019_0371_1 crossref_primary_10_12688_f1000research_131522_1 crossref_primary_10_1021_acsomega_3c00634 crossref_primary_10_2174_1574888X17666220511151343 crossref_primary_10_1007_s00018_022_04266_6 crossref_primary_10_3389_fchem_2021_664097 crossref_primary_10_4254_wjh_v15_i2_201 crossref_primary_10_1007_s10120_023_01366_5 crossref_primary_10_1002_cmdc_202100514 crossref_primary_10_12677_ACM_2023_1351004 crossref_primary_10_3390_pharmaceutics15071868 crossref_primary_10_3390_ijms24043298 crossref_primary_10_1016_j_ejmcr_2024_100170 crossref_primary_10_3390_s24010037 crossref_primary_10_1038_s41598_019_47658_8 crossref_primary_10_1038_s41585_021_00562_1 crossref_primary_10_21931_RB_CSS_2023_08_01_14 crossref_primary_10_1186_s12935_018_0668_y crossref_primary_10_3389_fmolb_2020_00188 crossref_primary_10_3390_cancers15102680 crossref_primary_10_1016_j_ejphar_2022_175360 crossref_primary_10_3390_ijms24119617 crossref_primary_10_3390_v14071538 crossref_primary_10_1080_07391102_2021_1939788 crossref_primary_10_3389_fimmu_2020_01877 crossref_primary_10_4103_1673_5374_235022 crossref_primary_10_1002_term_2772 crossref_primary_10_1021_acs_chemrev_1c01032 crossref_primary_10_1038_s41581_019_0129_4 crossref_primary_10_3390_ijms23158273 crossref_primary_10_1515_hsz_2019_0413 crossref_primary_10_15570_actaapa_2020_22 crossref_primary_10_3390_cells13060515 crossref_primary_10_1080_17512433_2021_1894127 crossref_primary_10_1186_s40659_024_00490_5 crossref_primary_10_15570_actaapa_2020_17 crossref_primary_10_3389_fchem_2020_00593 crossref_primary_10_3389_fphar_2022_886198 crossref_primary_10_3390_ijms19102934 crossref_primary_10_3892_mmr_2022_12682 crossref_primary_10_1038_s41598_024_51383_2 crossref_primary_10_1039_D0CS01121E crossref_primary_10_1080_19490976_2021_1884515 crossref_primary_10_3390_cancers12010030 crossref_primary_10_1038_s41418_019_0317_6 crossref_primary_10_1042_BSR20193899 crossref_primary_10_15829_1728_8800_2024_3729 crossref_primary_10_2174_1389557519666190304120821 crossref_primary_10_3390_cancers13205203 crossref_primary_10_18821_0869_2084_2020_65_3_141_148 crossref_primary_10_1016_j_bpj_2022_10_008 crossref_primary_10_3389_fimmu_2018_01998 crossref_primary_10_1016_j_cytogfr_2021_03_004 crossref_primary_10_1177_20420188221142452 crossref_primary_10_1021_acscentsci_2c00215 crossref_primary_10_3390_ijms21239232 crossref_primary_10_1096_fj_202201001RR crossref_primary_10_1002_chem_202101752 crossref_primary_10_3390_biom10030389 crossref_primary_10_1016_j_phrs_2022_106301 crossref_primary_10_3390_molecules24244561 crossref_primary_10_3390_biom11111720 |
Cites_doi | 10.1016/j.canlet.2008.02.048 10.1016/j.jmb.2005.01.027 10.1074/jbc.M604506200 10.1039/B517529A 10.18632/oncotarget.13201 10.1186/s13058-016-0757-6 10.1158/1078-0432.CCR-06-2441 10.1016/S0304-4165(02)00311-2 10.1093/glycob/cwt005 10.1074/jbc.M010144200 10.1021/bi00052a033 10.1021/acs.jmedchem.6b00957 10.1007/s00109-012-0965-1 10.1016/S0304-4165(02)00313-6 10.1074/jbc.M606648200 10.1093/glycob/cwv073 10.1016/S0969-2126(01)00275-1 10.1093/glycob/7.3.323-a 10.1038/s41698-017-0030-1 10.1093/oxfordjournals.jbchem.a021192 10.1038/sj.bjc.6602493 10.1074/jbc.273.21.13047 10.1007/s10571-006-9059-3 10.3390/ijms18122671 10.1093/glycob/cwj056 10.1002/jcp.24865 10.1016/j.jhep.2010.09.020 10.1093/glycob/cwr173 10.1016/j.jmb.2010.02.033 10.1007/s004320000207 10.1073/pnas.0603883103 10.1021/bi990756e 10.1016/S0022-2836(02)00700-3 10.1093/glycob/cwl025 10.1038/sj.onc.1204950 10.1016/j.bbcan.2015.03.003 10.1074/jbc.270.10.5032 10.1074/jbc.M200981200 10.1093/glycob/cww021 10.1111/j.2047-2927.2013.00099.x 10.1074/jbc.270.11.5823 10.1021/bi9716478 10.1093/oxfordjournals.jbchem.a003148 10.1042/BJ20090265 10.1016/j.carres.2006.04.028 10.1016/S0021-9258(19)74214-8 10.1073/pnas.93.13.6737 10.1042/bj20030295 10.1073/pnas.96.20.11329 10.1002/ijc.20699 10.1667/RR1734.1 10.1158/1078-0432.743.11.2 10.1016/0014-5793(95)00100-N 10.18632/oncotarget.16208 10.1080/09553008914550631 10.1002/ijc.20850 10.1016/S0092-8674(00)80670-4 10.1021/ar700086k 10.1093/glycob/3.4.297 10.1371/journal.pone.0135607 10.1016/j.carres.2009.04.010 10.1056/NEJM199103213241210 10.1158/0008-5472.CAN-06-1609 10.1016/S0021-9258(18)48248-8 10.1038/nature02502 10.1038/nm988 10.1074/jbc.M312834200 10.4049/jimmunol.1202612 10.1139/v02-162 10.1093/glycob/cwu062 10.1021/bi981056x 10.1038/378736a0 10.1074/jbc.M200221200 10.1093/jnci/djj247 10.1046/j.1471-4159.1998.70020814.x 10.1093/glycob/9.10.979 10.1021/jm061053f 10.1021/bi050298b 10.1038/sj.onc.1203767 10.1371/journal.pone.0083481 10.1021/jm300014q 10.1016/j.bmcl.2005.02.079 10.1515/tumor-2015-0002 10.1016/j.radonc.2005.06.038 10.1167/iovs.16-20009 10.1093/carcin/bgq116 10.1073/pnas.91.4.1428 10.1021/bi00067a038 10.1073/pnas.72.4.1383 10.1038/nsb1294-863 10.1073/pnas.0511167103 10.1007/s10147-006-0625-y 10.1016/S0304-3835(03)00015-6 10.1021/bc900287y 10.1093/glycob/cwm001 10.1038/nm0901-987 10.1158/0008-5472.CAN-04-0026 10.1681/ASN.2013070773 10.1016/0167-4889(96)00031-6 10.1038/nrc1627 10.1093/carcin/bgh329 10.1016/j.jmb.2005.06.045 10.1039/b502354h 10.1016/j.cell.2014.01.043 10.1016/S0959-440X(02)00364-0 10.1016/S0021-9258(18)55075-4 10.1016/j.bmc.2005.09.050 10.1084/jem.170.6.1959 10.1124/jpet.112.199646 10.1074/jbc.M308608200 10.1038/cddis.2015.324 10.1016/j.ejca.2014.06.015 10.1016/j.bmcl.2005.05.084 10.3233/CBM-160661 10.4049/jimmunol.176.10.6323 10.1093/glycob/cwx071 10.1016/S0008-6215(00)90597-4 10.1016/j.jmb.2004.08.078 10.1093/glycob/cwr083 10.1002/1097-0134(20000815)40:3<378::AID-PROT40>3.0.CO;2-7 10.4052/tigg.9.9 10.1007/978-3-540-46410-5_4 10.1016/S0969-2126(00)80056-8 10.1007/s12253-013-9603-7 10.1158/1078-0432.CCR-10-2443 10.2174/1389450054022007 10.2174/092986706779026219 10.1006/jmbi.1999.3273 10.2174/157340606778250252 10.1038/cddis.2011.120 10.1016/S0021-9258(18)67499-X 10.1002/cmdc.201700744 10.18632/oncotarget.15341 10.1016/S0021-9258(19)49693-2 10.1016/j.str.2004.03.002 10.1002/anie.200500627 10.3892/or.18.2.483 10.3109/02656736.2010.510495 10.1074/jbc.271.51.33083 10.1021/acs.jmedchem.7b01626 10.1182/blood-2006-03-007153 10.1042/bj3540233 10.1038/nrc1527 10.1074/jbc.270.10.5198 10.1038/38525 10.1016/j.cellbi.2005.12.010 10.1016/S0304-4165(02)00310-0 10.1146/annurev.bb.24.060195.003003 10.3892/ijo.19.4.723 10.1007/s12035-014-8935-y 10.1093/glycob/cwh029 10.1002/1097-0142(19890101)63:1<37::AID-CNCR2820630106>3.0.CO;2-Z 10.1111/aji.12273 10.1667/RR2784.1 10.1200/JCO.2005.02.0206 10.1074/jbc.M200154200 10.4049/jimmunol.174.12.7516 10.18632/oncotarget.21212 10.1016/j.ccr.2004.10.011 10.1371/journal.pone.0075361 10.1016/S1535-6108(04)00024-8 10.1074/jbc.M412019200 10.1042/BCJ20170658 10.1093/glycob/12.3.199 10.1002/pros.21287 10.1097/HJH.0000000000001545 10.1021/jo060485v 10.1016/0092-8674(94)90498-7 10.1091/mbc.E16-05-0301 10.1038/sj.cdd.4401462 10.1002/pros.21236 10.1016/j.bmcl.2005.12.010 10.1021/ja043475p 10.1016/S0006-291X(03)00151-7 10.1096/fj.05-4493com |
ContentType | Journal Article |
Copyright | 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2018 by the authors. 2018 |
Copyright_xml | – notice: 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2018 by the authors. 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/ijms19030905 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest research library Research Library (Corporate) Access via ProQuest (Open Access) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | oai_doaj_org_article_b2b3562bde5a44efaabd8dbc9f10b446 10_3390_ijms19030905 29562695 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: T32 CA009138 |
GroupedDBID | --- 29J 2WC 3V. 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH ABDBF ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CGR CS3 CUY CVF D1I DIK DU5 DWQXO E3Z EBD EBS ECM EIF EJD ESTFP ESX F5P FRP FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HH5 HMCUK HYE IAO IPNFZ ITC KB. KQ8 LK8 M1P M2O M48 M7P MODMG M~E NPM O5R O5S OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 TUS UKHRP ~8M AAYXX AFPKN CITATION 7XB 8FK K9. MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c544t-a342b2d08d1df0e7980eb3212b419ef1060ad80987682fde7bb7df0e0e39ae5b3 |
IEDL.DBID | RPM |
ISSN | 1422-0067 1661-6596 |
IngestDate | Tue Oct 22 15:07:04 EDT 2024 Tue Sep 17 21:22:31 EDT 2024 Fri Oct 25 10:31:11 EDT 2024 Thu Oct 10 16:42:15 EDT 2024 Thu Sep 26 15:48:01 EDT 2024 Sat Nov 02 12:24:13 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | carbohydrates protein structure galectins cell adhesion apoptosis galectin-targeted therapeutics cancer |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c544t-a342b2d08d1df0e7980eb3212b419ef1060ad80987682fde7bb7df0e0e39ae5b3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0001-7686-1331 0000-0002-7860-5785 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877766/ |
PMID | 29562695 |
PQID | 2108450172 |
PQPubID | 2032341 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b2b3562bde5a44efaabd8dbc9f10b446 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5877766 proquest_miscellaneous_2017056142 proquest_journals_2108450172 crossref_primary_10_3390_ijms19030905 pubmed_primary_29562695 |
PublicationCentury | 2000 |
PublicationDate | 2018-03-19 |
PublicationDateYYYYMMDD | 2018-03-19 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-19 day: 19 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2018 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | ref57 Hsu (ref45) 1992; 267 ref56 ref59 ref58 ref52 ref168 ref54 ref169 Dings (ref155) 2008 ref170 ref177 ref178 ref51 ref175 Nesmelova (ref8) 2008 ref50 ref173 ref174 ref171 ref172 ref46 ref48 ref47 ref42 ref41 ref179 Woo (ref43) 1991; 266 ref49 Leffler (ref55) 1986; 261 ref180 ref7 ref181 ref9 ref4 ref3 ref6 ref5 ref100 Leffler (ref44) 2001; 33 ref101 ref40 ref182 ref183 ref35 ref34 ref37 Sparrow (ref53) 1987; 262 ref36 ref31 ref148 ref30 ref149 ref33 ref146 ref32 ref147 ref39 ref38 ref156 ref153 ref151 ref152 ref150 ref24 ref23 ref26 ref25 ref20 ref159 ref22 ref157 ref21 ref158 ref28 ref27 Akahani (ref66) 1997; 57 ref29 ref166 Zheng (ref96) 2016; 8 ref167 ref164 ref165 ref162 ref163 ref160 ref161 ref13 ref12 ref15 ref128 ref14 ref129 ref97 ref126 ref127 ref11 ref99 ref124 ref98 ref125 ref17 ref16 ref19 ref18 Lobsanov (ref10) 1993; 268 ref93 ref133 ref92 ref134 ref95 ref131 ref94 ref132 ref130 ref91 ref90 Ansiaux (ref154) 2005; 11 ref89 ref139 ref86 ref85 ref138 ref88 ref135 ref87 ref136 Dings (ref137) 2003; 63 ref82 ref144 ref81 ref145 ref84 ref142 ref83 ref143 ref140 ref141 ref80 ref79 ref108 ref78 ref109 ref106 ref107 ref75 ref104 ref74 ref105 ref77 ref102 ref76 ref103 ref2 ref1 ref71 ref111 ref70 ref112 ref73 ref72 ref110 ref68 ref119 ref67 ref117 ref69 ref118 ref64 ref115 ref63 ref116 ref113 ref65 ref114 Gray (ref176) 1959; 2 ref60 ref122 ref123 ref62 ref120 ref61 ref121 |
References_xml | – ident: ref151 doi: 10.1016/j.canlet.2008.02.048 – ident: ref26 doi: 10.1016/j.jmb.2005.01.027 – ident: ref81 doi: 10.1074/jbc.M604506200 – ident: ref121 doi: 10.1039/B517529A – ident: ref95 doi: 10.18632/oncotarget.13201 – ident: ref105 doi: 10.1186/s13058-016-0757-6 – ident: ref156 doi: 10.1158/1078-0432.CCR-06-2441 – ident: ref52 doi: 10.1016/S0304-4165(02)00311-2 – ident: ref82 doi: 10.1093/glycob/cwt005 – ident: ref177 doi: 10.1074/jbc.M010144200 – ident: ref40 doi: 10.1021/bi00052a033 – ident: ref123 doi: 10.1021/acs.jmedchem.6b00957 – ident: ref169 doi: 10.1007/s00109-012-0965-1 – ident: ref109 doi: 10.1016/S0304-4165(02)00313-6 – ident: ref20 doi: 10.1074/jbc.M606648200 – ident: ref61 doi: 10.1093/glycob/cwv073 – ident: ref16 doi: 10.1016/S0969-2126(01)00275-1 – ident: ref30 doi: 10.1093/glycob/7.3.323-a – ident: ref13 – ident: ref168 doi: 10.1038/s41698-017-0030-1 – ident: ref7 doi: 10.1093/oxfordjournals.jbchem.a021192 – ident: ref133 doi: 10.1038/sj.bjc.6602493 – ident: ref11 doi: 10.1074/jbc.273.21.13047 – ident: ref84 doi: 10.1007/s10571-006-9059-3 – ident: ref159 doi: 10.3390/ijms18122671 – ident: ref119 doi: 10.1093/glycob/cwj056 – ident: ref92 doi: 10.1002/jcp.24865 – ident: ref128 doi: 10.1016/j.jhep.2010.09.020 – volume: 57 start-page: 5272 year: 1997 ident: ref66 article-title: Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family publication-title: Cancer Res. contributor: fullname: Akahani – ident: ref60 doi: 10.1093/glycob/cwr173 – ident: ref36 doi: 10.1016/j.jmb.2010.02.033 – ident: ref74 doi: 10.1007/s004320000207 – ident: ref108 doi: 10.1073/pnas.0603883103 – volume: 63 start-page: 382 year: 2003 ident: ref137 article-title: The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin publication-title: Cancer Res. contributor: fullname: Dings – ident: ref15 doi: 10.1021/bi990756e – ident: ref25 doi: 10.1016/S0022-2836(02)00700-3 – ident: ref1 doi: 10.1093/glycob/cwl025 – ident: ref85 doi: 10.1038/sj.onc.1204950 – ident: ref162 doi: 10.1016/j.bbcan.2015.03.003 – ident: ref31 doi: 10.1074/jbc.270.10.5032 – ident: ref107 doi: 10.1074/jbc.M200981200 – ident: ref38 doi: 10.1093/glycob/cww021 – ident: ref103 doi: 10.1111/j.2047-2927.2013.00099.x – ident: ref32 doi: 10.1074/jbc.270.11.5823 – ident: ref51 doi: 10.1021/bi9716478 – ident: ref83 doi: 10.1093/oxfordjournals.jbchem.a003148 – ident: ref59 doi: 10.1042/BJ20090265 – ident: ref117 doi: 10.1016/j.carres.2006.04.028 – volume: 268 start-page: 27034 year: 1993 ident: ref10 article-title: X-ray crystal structure of the human dimeric S-Lac lectin, L-14-II, in complex with lactose at 2.9-A resolution publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)74214-8 contributor: fullname: Lobsanov – ident: ref65 doi: 10.1073/pnas.93.13.6737 – ident: ref142 doi: 10.1042/bj20030295 – ident: ref72 doi: 10.1073/pnas.96.20.11329 – ident: ref80 doi: 10.1002/ijc.20699 – ident: ref182 doi: 10.1667/RR1734.1 – volume: 11 start-page: 743 year: 2005 ident: ref154 article-title: Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.743.11.2 contributor: fullname: Ansiaux – ident: ref46 doi: 10.1016/0014-5793(95)00100-N – ident: ref164 doi: 10.18632/oncotarget.16208 – ident: ref175 doi: 10.1080/09553008914550631 – ident: ref138 doi: 10.1002/ijc.20850 – ident: ref87 doi: 10.1016/S0092-8674(00)80670-4 – ident: ref144 doi: 10.1021/ar700086k – start-page: 306 year: 2008 ident: ref155 article-title: Cancer drug discovery and development contributor: fullname: Dings – ident: ref6 doi: 10.1093/glycob/3.4.297 – ident: ref173 doi: 10.1371/journal.pone.0135607 – ident: ref58 doi: 10.1016/j.carres.2009.04.010 – ident: ref167 doi: 10.1056/NEJM199103213241210 – ident: ref135 doi: 10.1158/0008-5472.CAN-06-1609 – volume: 262 start-page: 7383 year: 1987 ident: ref53 article-title: Multiple soluble beta-galactoside-binding lectins from human lung publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)48248-8 contributor: fullname: Sparrow – ident: ref71 doi: 10.1038/nature02502 – ident: ref149 doi: 10.1038/nm988 – ident: ref47 doi: 10.1074/jbc.M312834200 – ident: ref180 doi: 10.4049/jimmunol.1202612 – ident: ref35 doi: 10.1139/v02-162 – ident: ref165 doi: 10.1093/glycob/cwu062 – volume: 8 start-page: 1641 year: 2016 ident: ref96 article-title: Galectin-1 mediates TGF-beta-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer publication-title: Am. J. Transl. Res. contributor: fullname: Zheng – ident: ref14 doi: 10.1021/bi981056x – ident: ref69 doi: 10.1038/378736a0 – ident: ref17 doi: 10.1074/jbc.M200221200 – ident: ref146 doi: 10.1093/jnci/djj247 – ident: ref42 doi: 10.1046/j.1471-4159.1998.70020814.x – ident: ref4 doi: 10.1093/glycob/9.10.979 – ident: ref88 doi: 10.1021/jm061053f – ident: ref56 doi: 10.1021/bi050298b – ident: ref75 doi: 10.1038/sj.onc.1203767 – ident: ref130 doi: 10.1371/journal.pone.0083481 – ident: ref141 doi: 10.1021/jm300014q – ident: ref112 doi: 10.1016/j.bmcl.2005.02.079 – ident: ref183 doi: 10.1515/tumor-2015-0002 – ident: ref174 doi: 10.1016/j.radonc.2005.06.038 – ident: ref124 doi: 10.1167/iovs.16-20009 – ident: ref172 doi: 10.1093/carcin/bgq116 – year: 2008 ident: ref8 article-title: Understanding galectin structure-function relationships to design effective antagonists contributor: fullname: Nesmelova – ident: ref19 doi: 10.1073/pnas.91.4.1428 – ident: ref41 doi: 10.1021/bi00067a038 – ident: ref2 doi: 10.1073/pnas.72.4.1383 – ident: ref18 doi: 10.1038/nsb1294-863 – ident: ref127 doi: 10.1073/pnas.0511167103 – ident: ref147 doi: 10.1007/s10147-006-0625-y – ident: ref136 doi: 10.1016/S0304-3835(03)00015-6 – ident: ref158 doi: 10.1021/bc900287y – ident: ref48 doi: 10.1093/glycob/cwm001 – ident: ref152 doi: 10.1038/nm0901-987 – ident: ref86 doi: 10.1158/0008-5472.CAN-04-0026 – ident: ref93 doi: 10.1681/ASN.2013070773 – ident: ref67 doi: 10.1016/0167-4889(96)00031-6 – ident: ref68 doi: 10.1038/nrc1627 – ident: ref131 doi: 10.1093/carcin/bgh329 – ident: ref28 doi: 10.1016/j.jmb.2005.06.045 – ident: ref113 doi: 10.1039/b502354h – ident: ref157 doi: 10.1016/j.cell.2014.01.043 – ident: ref64 doi: 10.1016/S0959-440X(02)00364-0 – volume: 266 start-page: 18419 year: 1991 ident: ref43 article-title: Carbohydrate-binding protein 35 (Mac-2), a laminin-binding lectin, forms functional dimers using cysteine 186 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)55075-4 contributor: fullname: Woo – ident: ref114 doi: 10.1016/j.bmc.2005.09.050 – ident: ref78 doi: 10.1084/jem.170.6.1959 – ident: ref143 doi: 10.1124/jpet.112.199646 – ident: ref145 doi: 10.1074/jbc.M308608200 – ident: ref91 doi: 10.1038/cddis.2015.324 – ident: ref160 doi: 10.1016/j.ejca.2014.06.015 – volume: 2 start-page: 69 year: 1959 ident: ref176 article-title: The influence of oxygen and peroxides on the response of mammalian cells and tissues to ionizing radiations publication-title: Prog. Nucl. Energy 6 Biol. Sci. contributor: fullname: Gray – ident: ref111 doi: 10.1016/j.bmcl.2005.05.084 – ident: ref99 doi: 10.3233/CBM-160661 – ident: ref181 doi: 10.4049/jimmunol.176.10.6323 – ident: ref62 doi: 10.1093/glycob/cwx071 – ident: ref140 doi: 10.1016/S0008-6215(00)90597-4 – ident: ref9 doi: 10.1016/j.jmb.2004.08.078 – ident: ref50 doi: 10.1093/glycob/cwr083 – ident: ref21 doi: 10.1002/1097-0134(20000815)40:3<378::AID-PROT40>3.0.CO;2-7 – ident: ref33 doi: 10.4052/tigg.9.9 – volume: 33 start-page: 57 year: 2001 ident: ref44 article-title: Galectins structure and function—A synopsis publication-title: Results Probl. Cell Differ. doi: 10.1007/978-3-540-46410-5_4 contributor: fullname: Leffler – ident: ref24 doi: 10.1016/S0969-2126(00)80056-8 – ident: ref118 – ident: ref100 doi: 10.1007/s12253-013-9603-7 – ident: ref161 doi: 10.1158/1078-0432.CCR-10-2443 – ident: ref49 doi: 10.2174/1389450054022007 – ident: ref110 doi: 10.2174/092986706779026219 – ident: ref23 doi: 10.1006/jmbi.1999.3273 – ident: ref120 doi: 10.2174/157340606778250252 – ident: ref178 doi: 10.1038/cddis.2011.120 – volume: 261 start-page: 10119 year: 1986 ident: ref55 article-title: Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)67499-X contributor: fullname: Leffler – ident: ref126 doi: 10.1002/cmdc.201700744 – ident: ref163 doi: 10.18632/oncotarget.15341 – volume: 267 start-page: 14167 year: 1992 ident: ref45 article-title: Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)49693-2 contributor: fullname: Hsu – ident: ref27 doi: 10.1016/j.str.2004.03.002 – ident: ref115 doi: 10.1002/anie.200500627 – ident: ref170 doi: 10.3892/or.18.2.483 – ident: ref150 doi: 10.3109/02656736.2010.510495 – ident: ref22 doi: 10.1074/jbc.271.51.33083 – ident: ref125 doi: 10.1021/acs.jmedchem.7b01626 – ident: ref70 doi: 10.1182/blood-2006-03-007153 – ident: ref132 doi: 10.1042/bj3540233 – ident: ref63 doi: 10.1038/nrc1527 – ident: ref29 doi: 10.1074/jbc.270.10.5198 – ident: ref73 doi: 10.1038/38525 – ident: ref79 doi: 10.1016/j.cellbi.2005.12.010 – ident: ref5 doi: 10.1016/S0304-4165(02)00310-0 – ident: ref39 doi: 10.1146/annurev.bb.24.060195.003003 – ident: ref77 doi: 10.3892/ijo.19.4.723 – ident: ref94 doi: 10.1007/s12035-014-8935-y – ident: ref34 doi: 10.1093/glycob/cwh029 – ident: ref166 doi: 10.1002/1097-0142(19890101)63:1<37::AID-CNCR2820630106>3.0.CO;2-Z – ident: ref104 doi: 10.1111/aji.12273 – ident: ref148 doi: 10.1667/RR2784.1 – ident: ref171 doi: 10.1200/JCO.2005.02.0206 – ident: ref90 doi: 10.1074/jbc.M200154200 – ident: ref179 doi: 10.4049/jimmunol.174.12.7516 – ident: ref97 doi: 10.18632/oncotarget.21212 – ident: ref153 doi: 10.1016/j.ccr.2004.10.011 – ident: ref129 doi: 10.1371/journal.pone.0075361 – ident: ref139 doi: 10.1016/S1535-6108(04)00024-8 – ident: ref57 doi: 10.1074/jbc.M412019200 – ident: ref37 doi: 10.1042/BCJ20170658 – ident: ref54 doi: 10.1093/glycob/12.3.199 – ident: ref102 doi: 10.1002/pros.21287 – ident: ref98 doi: 10.1097/HJH.0000000000001545 – ident: ref116 doi: 10.1021/jo060485v – ident: ref3 doi: 10.1016/0092-8674(94)90498-7 – ident: ref106 doi: 10.1091/mbc.E16-05-0301 – ident: ref76 doi: 10.1038/sj.cdd.4401462 – ident: ref101 doi: 10.1002/pros.21236 – ident: ref122 doi: 10.1016/j.bmcl.2005.12.010 – ident: ref12 doi: 10.1021/ja043475p – ident: ref89 doi: 10.1016/S0006-291X(03)00151-7 – ident: ref134 doi: 10.1096/fj.05-4493com |
SSID | ssj0023259 |
Score | 2.5304582 |
SecondaryResourceType | review_article |
Snippet | Galectins are a family of small, highly conserved, molecular effectors that mediate various biological processes, including chemotaxis and angiogenesis, and... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 905 |
SubjectTerms | Amino acids Angiogenesis Animals Apoptosis Binding sites Biological activity Cancer Carbohydrates Carbohydrates - chemistry cell adhesion Cell surface Chemical bonds Chemotaxis Drug Therapy, Combination Epitopes galectin-targeted therapeutics galectins Galectins - chemistry Galectins - metabolism Glycoconjugates Humans Lactose Molecular Targeted Therapy protein structure Proteins Review Sandwiches Structure-function relationships |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA4yELyIv51OiaDHsrRJ2gRPKs4pzNMGu5WkSXGCndjt4H_vS9rOTgQvXpscXt9L876vefkeQpfaiaAJpgLBpQyYMDRQsJaC0AK-t76xsTvRHT3Hwwl7mvJpq9WXqwmr5IErx_V1pCnkaG0sV4zZXClthNGZzEOigcv43ZfIhkzVVIsCqq_K3CmQ-v7s9a2EzEeJdG3qWgnI6_T_Bi5_1ki2ks5gB23XaBHfVFbuog1b7KHNqn_k5z66flDur_usKLEq8ajpdIvHvry7xABI8fj7ghV-bBU4HqDJ4H58NwzqbghBxhlbBIqySEeGCBOanNhECgJEGDKPZqG04I2YKCOIhO1NRLmxidaJm0gslcpyTQ9Rp5gX9hjhKHdXYjNNTW5YnFmArjJRbvMkilMmu-iqcVH6XolepEAWnCvTtiu76Nb5bzXHSVX7BxDAtA5g-lcAu6jXeD-tv58yhZAKxh0_7aKL1TCsfHecoQo7X8IcLwUE8ALmHFXBWlkSAe2LYgkWJmthXDN1faSYvXh1be4UEuP45D_e7RRtgZX-DmMoe6iz-FjaMwAxC33u1-sXncDyXg priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-ELyIb9cXFfQYbPNoEzyIiusD9LSCt5I0qa5gV-168N87k3bXXRGvzUCHSTIzXzKZj5BDi03QlDBUSa2pUI5TA2uJJh7yex-IjfFG9-4-vX4Qt4_ysT1wq9uyypFPDI7aDQo8Iz8GaKKERMRy-vZOkTUKb1dbCo1ZMp-wLEPwpbpXY8DFWSBLSyAG0VTqtCl85wDzj_svrzXEQh5rJK6bCEmhc_9f6ebvqsmJMNRdJktt_hidNRO-QmZ8tUoWGkbJrzVycmXwHL5f1ZGpo7sR923UCwXfdQQpatT7eXIV3UyUPK6Th-5l7-KatvwItJBCDKnhglnmYuUSV8Y-0yoGaAyxyIpE-xLAXmycijU4PMVK5zNrMxSMPdfGS8s3yFw1qPwWiViJj2QLy13pRFp4SGZ1ZtCdxkZyoTvkaGSi_K1pg5EDfEBT5pOm7JBztN9YBptXhw-Dj6e83Qu5ZZZD2mWdl0YIXxpjnXK20KCyBXjaIbsj6-ftjqrzn_nvkIPxMOwFvOAwlR98gkxoDgQJB8hsNpM11oQBEGSpBg2zqWmcUnV6pOo_h37bEnsmpun2_2rtkEX4f3ivmOhdMjf8-PR7kLAM7X5Yld9aB-nR priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fS8MwEA5jIvgi_rY6pYI-Vrs2bRNERMU5hfm0wd5KsqQ60U7XDdx_713azlV98LVJ4bj8uO9LLt8RcixRBI1R4bCAc4cy5TsC5pLT1IDvtSlsjDe6ncew3aMP_aBfI2W10cKB2Z_UDutJ9cavp58fs0tY8BfIOIGynw1f3jKIa77LUcx0yaPA0TGJj87vEwA2mLJpeODh4Aadp8D_-rsSnIyG_1_A82f-5EJAaq2R1QJJ2lf50K-Tmk43yHJeW3K2Sc7vBJ7ID9PMFpndKavg2l2T-p3ZAFbt7vfjK_t-Iflxi_Rat92btlNUSnAGAaUTR_jUk55ymWqqxNURZy6QZIhKkja5ToD2uUIxl8PWx7xE6UjKCDu62udCB9LfJvV0lOpdYnsJPpcdSF8lioYDDbCWRwI3VlcEPuUWOSldFL_nghgxEAl0ZbzoSotco__mfVDG2nwYjZ_iYlXE0pM-ADCpdCAo1YkQUjElBxxMlkBULdIovR-XUyMGkspogNzVIkfzZlgVeNUhUj2aQh8jEwTQA_rs5IM1t8QDSuiFHCyMKsNYMbXakg6fjfJ2gOqJYbj3Tx_skxUwxDxhbPIGqU_GU30AGGYiD830_AKAJe8y priority: 102 providerName: Scholars Portal |
Title | Galectins as Molecular Targets for Therapeutic Intervention |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29562695 https://www.proquest.com/docview/2108450172 https://search.proquest.com/docview/2017056142 https://pubmed.ncbi.nlm.nih.gov/PMC5877766 https://doaj.org/article/b2b3562bde5a44efaabd8dbc9f10b446 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8BExIvCLbBAiwKEnsMdWM7scUTIAqbVISmIvUtsmOHdVrTipSH_fc7O0nXIp548UNykU53F9_97PsAONOuCZpgKhZcypgJQ2OFthT3Lcb31g82dje6w_v07pH9GPPxBvCuFsYn7Rd6cl79mZ5Xk18-t3I-LXpdnljvYXjNXRO7NO1twiYaaAfRW5RFMaBvMtwp4vne5Pe0RqdHiSRuSk2CeCBJ3TSJFTfku_W_FWK-zpRccT2DPdhtY8bosuFtHzZs9RG2mymSfz_Bxa1yZ--Tqo5UHQ27ebfRyCd51xGGpdHof5lV9H0lzfEzPA5uRtd3cTsTIS44Y4tYUZboxBBh-qYkNpOCIBxG_6NZX9oSAR5RRhCJm5xISmMzrTNHSCyVynJND2CrmlX2C0RJ6QpjC01NaVhaWAxgZabcFkoUp0wG8K0TUT5vWl_kCBmcVPNVqQZw5eS3pHENq_2D2fNT3qot14mmKHltLFeM2VIpbYTRhUSWNULSAE466eftX1TnCEcF4w6lBnC6fI327y41VGVnL0jjGwJhkIE0h42ylpx0yg4gW1PjGqvrb9DkfI_t1sSO3v3lMewga758sS9PYGvx_GK_Yvyy0CFa7TjDVQxuQ_hwdXP_8DP0ZwGh8ysc1yETobfqf9qx9zk |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,12068,12777,21400,24330,27936,27937,31731,31732,33385,33386,33756,33757,43322,43612,43817,53804,53806,74073,74363,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB5RUNVeKuhzyyuV2qNFEtuJLQ4IEMtCWU6LxC2yY4cuElkgy4F_z4yTXXarqtfYh9FMPDOfPTMfwE9LQ9CUMExJrZlQjjOD_xJLPOb3PhAb04vu8DIbXInza3ndXbg1XVnlzCcGR-0mJd2R7yE0UUISYjm4f2DEGkWvqx2FxhtYExxjNXWK90_ngIungSwtwRjEMqmztvCdI8zfG9_eNRgLeayJuG4hJIXJ_f9KN_-umlwIQ_11-NDlj9Fha_ANWPH1R3jbMko-f4L9U0P38OO6iUwTDWfct9EoFHw3Eaao0ei15So6Wyh5_AxX_ZPR8YB1_AislEJMmeEitamLlUtcFftcqxihMcYiKxLtKwR7sXEq1ujwVFo5n1ub08bYc228tPwLrNaT2n-DKK2oSba03FVOZKXHZFbnhtxpbCQXuge_Zioq7tsxGAXCB1JlsajKHhyR_uZ7aHh1-DB5vCm6s1DY1HJMu6zz0gjhK2OsU86WGkW2CE97sDXTftGdqKZ4tX8PfsyX8SzQA4ep_eQJ94ThQJhw4J6vrbHmkqQIBNNMo4T5khmXRF1eqcd_wrxtSTMTs-z7_8XahXeD0fCiuDi7_L0J71GW0LuY6C1YnT4--W1MXqZ2J_yhL1y97LM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7RoiIuCFpatiw0SOVobRLbiS0OiNfSAq162Ep7i-zYgUUiu212D_x7Zpzsq0K9xnMYjccz3xePZwBOLTVBU8IwJbVmQjnODPoSSzziex8GG9ON7sVldnYtvo3luKt_arqyymVMDIHaTUv6Rz5AaqKEJMYyqLqyiKvPw_ezG0YTpOimtRunsQMPc2Qp5PP5eE2-eBoGpyWYj1gmddYWwXOk_IPJ7z8N5kUeaxpit5GeQhf__0HPuxWUGylp-BSedFgy-tBu_jN44Ot92GunS_49gHdfDf2Tn9RNZJroYjkHNxqF4u8mQrgajdbPr6LzjfLH53A9_DL6dMa6WQmslELMmeEitamLlUtcFftcqxhpMuYlKxLtKyR-sXEq1hj8VFo5n1ubk2DsuTZeWn4Iu_W09i8gSit6MFta7ionstIjsNW5odAaG8mF7sHbpYmKWdsSo0AqQaYsNk3Zg49kv5UMNbIOH6a3P4vuXBQ2tRwhmHVeGiF8ZYx1ytlSo8oWqWoP-kvrF93paoq1L_TgzWoZzwVddpjaTxcoExoFIfhAmaN2s1aapEgK00yjhvnWNm6pur1ST36F3tuS-idm2fH9ap3AI3TO4sf55feX8BhVCc8YE92H3fntwr9CHDO3r4OD_gNisfDr |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Galectins+as+Molecular+Targets+for+Therapeutic+Intervention&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Dings%2C+Ruud&rft.au=Miller%2C+Michelle&rft.au=Griffin%2C+Robert&rft.au=Mayo%2C+Kevin&rft.date=2018-03-19&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=19&rft.issue=3&rft.spage=905&rft_id=info:doi/10.3390%2Fijms19030905&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms19030905 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |